NCT06327594Recruiting
Assessment System of Sarcopenia in Lung Cancer Patients
Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients
Source: ClinicalTrials.gov · Last updated 25 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 18 Mar 2024
- Start date
- 1 Nov 2023
- Primary completion date
- Nov 2027
- Lead sponsor
- West China Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06327594
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 1 Nov 2023 to the primary completion date, Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Amputated arm or leg.
- Severe oedema (oedema higher than knee level).
- Implantable pacemaker.
- Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.
Who the study is looking for
- Hospitalized patients scheduled for radical resection of lung cancer.
- With a CT/MRI examination within 1 week.
- The compliance of examination was good.
Age in the registry: 40 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xinyi Tang Coordinator of this site? Confirm its status | Chengdu | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.